No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]

The emergence of high-efficacy therapies for multiple sclerosis (MS), which target inflammation more effectively than traditional disease-modifying therapies, has led to a shift in MS management towards achieving the outcome assessment known as no evidence of disease activity (NEDA). The most common...

Descripción completa

Detalles Bibliográficos
Autores principales: Newsome, Scott D., Binns, Cherie, Kaunzner, Ulrike W., Morgan, Seth, Halper, June
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630288/
https://www.ncbi.nlm.nih.gov/pubmed/37819598
http://dx.doi.org/10.1007/s40120-023-00549-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630288/
https://www.ncbi.nlm.nih.gov/pubmed/37819598
http://dx.doi.org/10.1007/s40120-023-00549-7

Ejemplares similares